Profil
David Lambeth is the founder of Calliditas Therapeutics Suisse SA, which was founded in 2006.
He is currently a Professor at Emory University School of Medicine, where he has been working since 1980.
Dr. Lambeth received a doctorate degree from Duke University.
Aktiva positioner av David Lambeth
| Företag | Position | Start |
|---|---|---|
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 1980-01-01 |
Tidigare kända positioner av David Lambeth
| Företag | Position | Slut |
|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Grundare | - |
David Lambeths utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Develops small molecule therapeutics that selectively inhibit NOX enzymes | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University School of Medicine
Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















